Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 14

1.

Clearance dynamics of lactate dehydrogenase and aldolase following antimalarial treatment for Plasmodium falciparum infection.

Plucinski MM, McElroy PD, Dimbu PR, Fortes F, Nace D, Halsey ES, Rogier E.

Parasit Vectors. 2019 Jun 10;12(1):293. doi: 10.1186/s13071-019-3549-x.

2.

Malaria Parasite Density in Individuals with Different Rapid Diagnostic Test Results and Concentrations of HRP2 Antigen.

Plucinski MM, Dimbu PR, Fortes F, Murphy SC, Smith NT, Cruz KR, Seilie AM, Halsey ES, Aidoo M, Rogier E.

Am J Trop Med Hyg. 2019 May;100(5):1202-1203. doi: 10.4269/ajtmh.19-0006.

PMID:
30915959
3.

Performance of Antigen Concentration Thresholds for Attributing Fever to Malaria among Outpatients in Angola.

Plucinski MM, Rogier E, Dimbu PR, Fortes F, Halsey ES, Aidoo M, Smith T.

J Clin Microbiol. 2019 Feb 27;57(3). pii: e01901-18. doi: 10.1128/JCM.01901-18. Print 2019 Mar.

4.

Efficacy and safety of artemether-lumefantrine, artesunate-amodiaquine, and dihydroartemisinin-piperaquine for the treatment of uncomplicated Plasmodium falciparum malaria in three provinces in Angola, 2017.

Davlantes E, Dimbu PR, Ferreira CM, Florinda Joao M, Pode D, Félix J, Sanhangala E, Andrade BN, Dos Santos Souza S, Talundzic E, Udhayakumar V, Owens C, Mbounga E, Wiesner L, Halsey ES, Martins JF, Fortes F, Plucinski MM.

Malar J. 2018 Apr 3;17(1):144. doi: 10.1186/s12936-018-2290-9.

5.

Prevalence of molecular markers of artemisinin and lumefantrine resistance among patients with uncomplicated Plasmodium falciparum malaria in three provinces in Angola, 2015.

Ljolje D, Dimbu PR, Kelley J, Goldman I, Nace D, Macaia A, Halsey ES, Ringwald P, Fortes F, Udhayakumar V, Talundzic E, Lucchi NW, Plucinski MM.

Malar J. 2018 Feb 20;17(1):84. doi: 10.1186/s12936-018-2233-5.

6.

Posttreatment HRP2 Clearance in Patients with Uncomplicated Plasmodium falciparum Malaria.

Plucinski MM, Dimbu PR, Fortes F, Abdulla S, Ahmed S, Gutman J, Kachur SP, Badiane A, Ndiaye D, Talundzic E, Lucchi N, Aidoo M, Udhayakumar V, Halsey E, Rogier E.

J Infect Dis. 2018 Feb 14;217(5):685-692. doi: 10.1093/infdis/jix622.

PMID:
29220497
7.

Capacity Development through the US President's Malaria Initiative-Supported Antimalarial Resistance Monitoring in Africa Network.

Halsey ES, Venkatesan M, Plucinski MM, Talundzic E, Lucchi NW, Zhou Z, Mandara CI, Moonga H, Hamainza B, Beavogui AH, Kariuki S, Samuels AM, Steinhardt LC, Mathanga DP, Gutman J, Denon YE, Uwimana A, Assefa A, Hwang J, Shi YP, Dimbu PR, Koita O, Ishengoma DS, Ndiaye D, Udhayakumar V.

Emerg Infect Dis. 2017 Dec;23(13). doi: 10.3201/eid2313.170366.

8.

Estimating the Added Utility of Highly Sensitive Histidine-Rich Protein 2 Detection in Outpatient Clinics in Sub-Saharan Africa.

Plucinski MM, Rogier E, Dimbu PR, Fortes F, Halsey ES, Aidoo M.

Am J Trop Med Hyg. 2017 Oct;97(4):1159-1162. doi: 10.4269/ajtmh.17-0262. Epub 2017 Jul 19.

9.

Evaluating malaria case management at public health facilities in two provinces in Angola.

Plucinski MM, Ferreira M, Ferreira CM, Burns J, Gaparayi P, João L, da Costa O, Gill P, Samutondo C, Quivinja J, Mbounga E, de León GP, Halsey ES, Dimbu PR, Fortes F.

Malar J. 2017 May 3;16(1):186. doi: 10.1186/s12936-017-1843-7.

10.

Efficacy of artemether-lumefantrine, artesunate-amodiaquine, and dihydroartemisinin-piperaquine for treatment of uncomplicated Plasmodium falciparum malaria in Angola, 2015.

Plucinski MM, Dimbu PR, Macaia AP, Ferreira CM, Samutondo C, Quivinja J, Afonso M, Kiniffo R, Mbounga E, Kelley JS, Patel DS, He Y, Talundzic E, Garrett DO, Halsey ES, Udhayakumar V, Ringwald P, Fortes F.

Malar J. 2017 Feb 2;16(1):62. doi: 10.1186/s12936-017-1712-4.

11.

Within-host competition and drug resistance in the human malaria parasite Plasmodium falciparum.

Bushman M, Morton L, Duah N, Quashie N, Abuaku B, Koram KA, Dimbu PR, Plucinski M, Gutman J, Lyaruu P, Kachur SP, de Roode JC, Udhayakumar V.

Proc Biol Sci. 2016 Mar 16;283(1826):20153038. doi: 10.1098/rspb.2015.3038.

12.

Reply to "no robust evidence of lumefantrine resistance".

Plucinski MM, Talundzic E, Morton L, Dimbu PR, Macaia AP, Fortes F, Goldman I, Lucchi N, Stennies G, MacArthur JR, Udhayakumar V.

Antimicrob Agents Chemother. 2015 Sep;59(9):5867-8. doi: 10.1128/AAC.01355-15. No abstract available.

13.

Robust Algorithm for Systematic Classification of Malaria Late Treatment Failures as Recrudescence or Reinfection Using Microsatellite Genotyping.

Plucinski MM, Morton L, Bushman M, Dimbu PR, Udhayakumar V.

Antimicrob Agents Chemother. 2015 Oct;59(10):6096-100. doi: 10.1128/AAC.00072-15. Epub 2015 Jul 20.

14.

Efficacy of artemether-lumefantrine and dihydroartemisinin-piperaquine for treatment of uncomplicated malaria in children in Zaire and Uíge Provinces, angola.

Plucinski MM, Talundzic E, Morton L, Dimbu PR, Macaia AP, Fortes F, Goldman I, Lucchi N, Stennies G, MacArthur JR, Udhayakumar V.

Antimicrob Agents Chemother. 2015 Jan;59(1):437-43. doi: 10.1128/AAC.04181-14. Epub 2014 Nov 3.

Supplemental Content

Loading ...
Support Center